There will be scheduled maintenance work beginning on Wednesday 26th February 2020 from 11:00 AM through to 12.00 PM (GMT).

During this time, you may not be able to log into ChemSpider. We apologise for any inconvenience this might cause and thank you for your patience.

ChemSpider 2D Image | Berzosertib | C24H25N5O3S


  • Molecular FormulaC24H25N5O3S
  • Average mass463.552 Da
  • Monoisotopic mass463.167816 Da
  • ChemSpider ID30773968

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

1232416-25-9 [RN]
2-Pyrazinamine, 3-[3-[4-[(methylamino)methyl]phenyl]-5-isoxazolyl]-5-[4-[(1-methylethyl)sulfonyl]phenyl]- [ACD/Index Name]
5-[4-(Isopropylsulfonyl)phenyl]-3-(3-{4-[(methylamino)methyl]phenyl}-1,2-oxazol-5-yl)-2-pyrazinamin [German] [ACD/IUPAC Name]
5-[4-(Isopropylsulfonyl)phenyl]-3-(3-{4-[(methylamino)methyl]phenyl}-1,2-oxazol-5-yl)-2-pyrazinamine [ACD/IUPAC Name]
5-[4-(Isopropylsulfonyl)phényl]-3-(3-{4-[(méthylamino)méthyl]phényl}-1,2-oxazol-5-yl)-2-pyrazinamine [French] [ACD/IUPAC Name]
berzosertib [French] [INN]
berzosertib [Spanish] [INN]
Berzosertib [INN] [USAN]
berzosertibum [Latin] [INN]

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

PubChem Substance ID 329825761 [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Safety:

      5 Axon Medchem 2452
      H303;H313;H317;H333;H334;H335;H374 Axon Medchem 2452
      no pictogram Axon Medchem 2452
      P101;P102;P103;P260;P262;P263;P264;P270;P280;P304;P312;P341 Axon Medchem 2452
      Warning Axon Medchem 2452
    • Target Organs:

      ATM/ATR inhibitor TargetMol T2669
    • Bio Activity:

      ATR MedChem Express HY-13902
      ATR/ATM TargetMol T2669
      Cell Cycle/DNA Damage MedChem Express HY-13902
      Cell Cycle/DNA Damage; MedChem Express HY-13902
      PI3K/Akt/mTOR Signaling TargetMol T2669
      VE-822 is a selective ATR inhibitor with an Ki value of 0.2 nM, >150 fold selectivity over ATM (Ki=34 nM), DNA-PK (Ki >4 uM) and mTOR (Ki >1 uM).; IC50 Value: 0.2 nM (Ki); 19 nM (Cell IC50) [1]; Target: ATR; in vitro: VE-822, a close analog of VE-821, has increased potency against ATR retaining the excellent ATR selectivity pro?le. MedChem Express HY-13902

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module

Density: 1.3±0.1 g/cm3
Boiling Point: 674.4±55.0 °C at 760 mmHg
Vapour Pressure: 0.0±2.1 mmHg at 25°C
Enthalpy of Vaporization: 99.0±3.0 kJ/mol
Flash Point: 361.7±31.5 °C
Index of Refraction: 1.603
Molar Refractivity: 126.0±0.4 cm3
#H bond acceptors: 8
#H bond donors: 3
#Freely Rotating Bonds: 7
#Rule of 5 Violations: 0
ACD/LogP: 3.36
ACD/LogD (pH 5.5): 0.21
ACD/BCF (pH 5.5): 1.00
ACD/KOC (pH 5.5): 1.46
ACD/LogD (pH 7.4): 1.65
ACD/BCF (pH 7.4): 4.70
ACD/KOC (pH 7.4): 40.28
Polar Surface Area: 132 Å2
Polarizability: 49.9±0.5 10-24cm3
Surface Tension: 53.9±3.0 dyne/cm
Molar Volume: 366.8±3.0 cm3

Click to predict properties on the Chemicalize site